Raymond W Cohen - Net Worth and Insider Trading
Raymond W Cohen Net Worth
The estimated net worth of Raymond W Cohen is at least $14 Million dollars as of 2024-10-13. Raymond W Cohen is the CEO of Axonics Inc and owns about 188,835 shares of Axonics Inc (AXNX) stock worth over $13 Million. Raymond W Cohen is the Director of BioLife Solutions Inc and owns about 22,763 shares of BioLife Solutions Inc (BLFS) stock worth over $514,444. Raymond W Cohen is also the Director of Spectrum Pharmaceuticals Inc and owns about 28,850 shares of Spectrum Pharmaceuticals Inc (SPPI) stock worth over $29,716. Details can be seen in Raymond W Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raymond W Cohen has not made any transactions after 2024-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raymond W Cohen
Raymond W Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raymond W Cohen owns 3 companies in total, including BioLife Solutions Inc (BLFS) , Axonics Inc (AXNX) , and Spectrum Pharmaceuticals Inc (SPPI) .
Click here to see the complete history of Raymond W Cohen’s form 4 insider trades.
Insider Ownership Summary of Raymond W Cohen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BLFS | BioLife Solutions Inc | 2020-11-12 | director |
AXNX | Axonics Inc | 2024-01-31 | director & Chief Executive Officer |
SPPI | Spectrum Pharmaceuticals Inc | 2018-05-14 | director |
Raymond W Cohen Latest Holdings Summary
Raymond W Cohen currently owns a total of 3 stocks. Among these stocks, Raymond W Cohen owns 188,835 shares of Axonics Inc (AXNX) as of January 31, 2024, with a value of $13 Million and a weighting of 96.06%. Raymond W Cohen owns 22,763 shares of BioLife Solutions Inc (BLFS) as of November 12, 2020, with a value of $514,444 and a weighting of 3.72%. Raymond W Cohen also owns 28,850 shares of Spectrum Pharmaceuticals Inc (SPPI) as of May 14, 2018, with a value of $29,716 and a weighting of 0.22%.
Latest Holdings of Raymond W Cohen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AXNX | Axonics Inc | 2024-01-31 | 188,835 | 70.30 | 13,275,101 |
BLFS | BioLife Solutions Inc | 2020-11-12 | 22,763 | 22.60 | 514,444 |
SPPI | Spectrum Pharmaceuticals Inc | 2018-05-14 | 28,850 | 1.03 | 29,716 |
Holding Weightings of Raymond W Cohen
Raymond W Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Raymond W Cohen has made a total of 19 transactions in Axonics Inc (AXNX) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Axonics Inc is the sale of 35,161 shares on January 31, 2024, which brought Raymond W Cohen around $2 Million.
According to the SEC Form 4 filings, Raymond W Cohen has made a total of 1 transactions in BioLife Solutions Inc (BLFS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in BioLife Solutions Inc is the sale of 5,625 shares on November 12, 2020, which brought Raymond W Cohen around $182,531.
According to the SEC Form 4 filings, Raymond W Cohen has made a total of 0 transactions in Spectrum Pharmaceuticals Inc (SPPI) over the past 5 years. The most-recent trade in Spectrum Pharmaceuticals Inc is the sale of 9,275 shares on May 14, 2018, which brought Raymond W Cohen around $169,918.
Insider Trading History of Raymond W Cohen
- 1
Raymond W Cohen Trading Performance
GuruFocus tracks the stock performance after each of Raymond W Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond W Cohen is -24.82%. GuruFocus also compares Raymond W Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond W Cohen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Raymond W Cohen's insider trading performs compared to the benchmark.
Performance of Raymond W Cohen
Raymond W Cohen Ownership Network
Raymond W Cohen Owned Company Details
What does BioLife Solutions Inc do?
Who are the key executives at BioLife Solutions Inc?
Raymond W Cohen is the director of BioLife Solutions Inc. Other key executives at BioLife Solutions Inc include Chief Tech. Officer & Sr. VP Aby J. Mathew , Chief Revenue Officer Garrie Richardson , and Vice President & Marketing Todd Berard .
BioLife Solutions Inc (BLFS) Insider Trades Summary
Over the past 18 months, Raymond W Cohen made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 114,907 shares made by Aby J. Mathew , a net sale of 43,698 shares made by Todd Berard , and a net sale of 16,910 shares made by Sarah Aebersold .
In summary, during the past 3 months, insiders sold 27,537 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 27,537 shares. During the past 18 months, 349,965 shares of BioLife Solutions Inc (BLFS) were sold and 1,135,630 shares were bought by its insiders, resulting in a net purchase of 785,665 shares.
BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioLife Solutions Inc Insider Transactions
Raymond W Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Raymond W Cohen. Currently GuruFocus does not have mailing address information for Raymond W Cohen.